Updated: Oct 10, 2026

Evan Wang's Stock Ratings

Guggenheim Analyst

Evan Wang is an analyst at Guggenheim. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends.

Overall Average Return

-59.5%

Smart Score

8.42%

Overall Average Return Percentile

2nd

Number of Ratings

8
Buy NowGet Alert
06/10/2025MTSRBuy Now
Metsera
——$56 → $62MaintainsBuyGet Alert
12/12/2024SPRBBuy Now
Spruce Biosciences
$44.02——ReiteratesNeutral → NeutralGet Alert
04/05/2024CVACBuy Now
CureVac
———Reiterates → NeutralGet Alert
04/05/2024IVVDBuy Now
Invivyd
$0.731132.88% → $9UpgradeNeutral → BuyGet Alert
03/22/2024VALNBuy Now
Valneva
$5.78194.12%$18 → $17MaintainsBuyGet Alert
03/14/2024SPRBBuy Now
Spruce Biosciences
$44.02——DowngradeBuy → NeutralGet Alert
02/21/2024SPRBBuy Now
Spruce Biosciences
$44.02-77.28% → $10Initiates → BuyGet Alert
04/26/2023MRNABuy Now
Moderna
$225.47——Initiates → NeutralGet Alert